BANNOCKBURN, Ill.—(PRWEB) November 5, 2010—Advanced Clinical, a leading provider of clinical research services, announces James C. Oliver, Pharm.D., as a core member of its strategic advisory ecosystem.
As a strategic advisor specializing in biologics, drugs, devices and protocol due diligence, Dr. Oliver brings more than 28 years of global clinical research experience to Advanced Clinical’s strategic advisory team. Currently Dr. Oliver, otherwise known as Jamie, is President and CEO of Trinity Drug Partners, LLC (http://www.trinitydrugpartners.com). He has an established background in bringing Investigational New Drugs (INDs) as well as Biological License Agreements (BLAs) to market. During his career, Dr. Oliver has participated in face to face meetings with nearly every review division in the FDA’s Office of New Drugs. In addition to extensive FDA experience and global regulatory strategy work with U.S., Asia-Pacific and European companies, Dr. Oliver has participated in licensing collaboration negotiations with immunology and cancer-based therapeutics. Dr. Oliver has also performed numerous medical reviews of manuscripts for peer-reviewed publications, statistical/data analysis plans, clinical study report write-ups, integrated summaries of safety and efficacy, as well as clinical research associate training.
“Dr. Oliver is a tremendous asset to Advanced Clinical given the depth and breadth of regulatory experience,” said Rosemarie Truman, Executive Vice President of Solutions at Advanced Clinical. Leo Sheridan, CEO of Advanced Clinical, added, “We are truly honored to have Dr. Oliver as part of our strategic ecosystem. He has added significant value in multiple avenues already, and we know that his contributions to our vision, ‘Advancing Discoveries through Insight,’ will create step-change value for the life sciences industry.”
"Being on Advanced Clinical’s ecosystem alongside other talented professionals is both a synergy of expertise and a dedication to the advancement of life sciences,” said Jamie Oliver, Advanced Clinical Strategic Advisor. “I am proud and honored to be working with the Advanced team.”
Dr. Oliver has held leadership positions at Peregrine Pharmaceuticals and Maret Pharmaceutical and Ockham Development Group, most recently as Chief Operating Officer/Head of Development and Chief Science Officer-President. In these roles, Jamie’s responsibilities included providing scientific oversight of all phases of clinical trial management including protocol development, study initiation, active research, database closure, medical monitoring and regulatory submissions document review. Additionally, Dr. Oliver was in charge of interfacing with regulatory agencies during the drug development process.
Dr. Oliver has a Pharm.D. and a Bachelor of Science in pharmacy, both from Mercer University School of Pharmacy (Atlanta, GA). He held academic appointments at the Mercer University School of Pharmacy, Emory University, and the University of North Carolina-Chapel Hill School of Pharmacy.
About Advanced Clinical: Advanced Clinical provides consulting services, strategic sourcing (CRO), talent management, and technology solutions to the Life Sciences industry. With 15+ years of experience, Advanced Clinical is an established presence in the clinical research field, providing services specifically for Pharmaceutical, Biopharmaceutical, Biotechnology and Medical Device organizations. Advanced utilizes a value-based, “One Team” approach. To learn more, visit http://www.advancedclinical.com.
1200 Lakeside Drive
Bannockburn, IL 60015